30
Participants
Start Date
September 27, 2024
Primary Completion Date
April 1, 2027
Study Completion Date
April 1, 2028
KC1036
For patients weighing between 30 kg and less than 50 kg, administer 40 mg QD of KC1036. For patients weighing between 50 kg and less than 70 kg, administer 50 mg QD of KC1036. For patients weighing 70 kg or more, administer 60 mg QD of KC1036. 4 weeks as a cycle.
RECRUITING
Beijing Children's Hospital Affiliated to Capital Medical University, Beijing
Beijing Konruns Pharmaceutical Co., Ltd.
INDUSTRY